| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |